Table 1.
Characteristics | All patients (n = 120) N (%) |
---|---|
Age (yr) | |
Median | 63 |
Range | 28–88 |
Gender | |
Male | 92 (76.7%) |
Female | 28 (23.3%) |
Smoking status | |
Smoker | 68 (56.7%) |
Non-smoker | 52 (43.3%) |
Histology | |
Adenocarcinoma | 105 (87.5%) |
Others NSCLC | 15 (12.5%) |
Stage | |
IV | 120 (100%) |
ALK test | |
FISH | 90 (75%) |
IHC | 30 (25%) |
EGFR status | |
Mutated | 21 (17.5%) |
Wild | 99 (82.5%) |
Kras status | |
Mutated | 7 (5.8%) |
Wild | 55 (45.8%) |
Not tested | 58 (48.3%) |
Yr year, NSCLC non small cell lung cancer, ALK anaplastic lymphoma kinase, FISH fluorescent in situ hybridization, IHC immunohistochemistry, EGFR epidermal growth factor receptor, Kras Kirsten rat sarcoma